Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6338234rdf:typepubmed:Citationlld:pubmed
pubmed-article:6338234lifeskim:mentionsumls-concept:C0035647lld:lifeskim
pubmed-article:6338234lifeskim:mentionsumls-concept:C0003374lld:lifeskim
pubmed-article:6338234lifeskim:mentionsumls-concept:C0045799lld:lifeskim
pubmed-article:6338234pubmed:issue1lld:pubmed
pubmed-article:6338234pubmed:dateCreated1983-4-7lld:pubmed
pubmed-article:6338234pubmed:abstractTextReduction of the azomethine bond of 2-acetylpyridine thio- and selenosemicarbazones with sodium borohydride readily afforded the corresponding thio- or selenosemicarbazides when they were N4,N4-disubstituted. This conversion failed, however, when the thio- or selenosemicarbazones were N4-substituted or unsubstituted. A more general route to the desired thio- or selenosemicarbazides consisted of reduction with sodium borohydride of methyl 3-[1-(2-pyridyl)ethylidene]hydrazinecarbodithioate to give the 2-pyridylethyl derivative. Displacement of methyl mercaptan from the thio ester moiety of the latter by amines produced 1-[1-(2-pyridyl)ethyl]-3-thiosemicarbazides. These compounds were somewhat more active as antimalarial agents in Plasmodium berghei infected mice than the corresponding thiosemicarbazones; however, the enhancement of activity was accompanied by an increase in toxicity. Compound 7, 3-azabicyclo[3.2.2]nonane-3-carbothioic acid 2-[1-(2-pyridyl)ethyl]hydrazide, is the most potent derivative of 2-acetylpyridine we have evaluated to date.lld:pubmed
pubmed-article:6338234pubmed:languageenglld:pubmed
pubmed-article:6338234pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6338234pubmed:citationSubsetIMlld:pubmed
pubmed-article:6338234pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6338234pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6338234pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6338234pubmed:statusMEDLINElld:pubmed
pubmed-article:6338234pubmed:monthJanlld:pubmed
pubmed-article:6338234pubmed:issn0022-2623lld:pubmed
pubmed-article:6338234pubmed:authorpubmed-author:KlaymanD LDLlld:pubmed
pubmed-article:6338234pubmed:authorpubmed-author:ScovillJ PJPlld:pubmed
pubmed-article:6338234pubmed:authorpubmed-author:BruceJJlld:pubmed
pubmed-article:6338234pubmed:authorpubmed-author:BartosevichJ...lld:pubmed
pubmed-article:6338234pubmed:issnTypePrintlld:pubmed
pubmed-article:6338234pubmed:volume26lld:pubmed
pubmed-article:6338234pubmed:ownerNLMlld:pubmed
pubmed-article:6338234pubmed:authorsCompleteYlld:pubmed
pubmed-article:6338234pubmed:pagination35-9lld:pubmed
pubmed-article:6338234pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:6338234pubmed:meshHeadingpubmed-meshheading:6338234-...lld:pubmed
pubmed-article:6338234pubmed:meshHeadingpubmed-meshheading:6338234-...lld:pubmed
pubmed-article:6338234pubmed:meshHeadingpubmed-meshheading:6338234-...lld:pubmed
pubmed-article:6338234pubmed:meshHeadingpubmed-meshheading:6338234-...lld:pubmed
pubmed-article:6338234pubmed:meshHeadingpubmed-meshheading:6338234-...lld:pubmed
pubmed-article:6338234pubmed:meshHeadingpubmed-meshheading:6338234-...lld:pubmed
pubmed-article:6338234pubmed:meshHeadingpubmed-meshheading:6338234-...lld:pubmed
pubmed-article:6338234pubmed:meshHeadingpubmed-meshheading:6338234-...lld:pubmed
pubmed-article:6338234pubmed:meshHeadingpubmed-meshheading:6338234-...lld:pubmed
pubmed-article:6338234pubmed:meshHeadingpubmed-meshheading:6338234-...lld:pubmed
pubmed-article:6338234pubmed:meshHeadingpubmed-meshheading:6338234-...lld:pubmed
pubmed-article:6338234pubmed:year1983lld:pubmed
pubmed-article:6338234pubmed:articleTitle2-Acetylpyridine thiosemicarbazones. 5. 1-[1-(2-Pyridyl)ethyl]-3-thiosemicarbazides as potential antimalarial agents.lld:pubmed
pubmed-article:6338234pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:6338234lld:chembl
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6338234lld:pubmed